170 related articles for article (PubMed ID: 20610881)
21. uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study.
Lootens L; Meuleman P; Pozo OJ; Van Eenoo P; Leroux-Roels G; Delbeke FT
Clin Chem; 2009 Oct; 55(10):1783-93. PubMed ID: 19643840
[TBL] [Abstract][Full Text] [Related]
22. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver.
Nishimura M; Yoshitsugu H; Yokoi T; Tateno C; Kataoka M; Horie T; Yoshizato K; Naito S
Xenobiotica; 2005 Sep; 35(9):877-90. PubMed ID: 16308282
[TBL] [Abstract][Full Text] [Related]
24. Organic Anion-Transporting Polypeptide (OATP)-Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver.
Uchida M; Tajima Y; Kakuni M; Kageyama Y; Okada T; Sakurada E; Tateno C; Hayashi R
Drug Metab Dispos; 2018 Jan; 46(1):11-19. PubMed ID: 29051147
[TBL] [Abstract][Full Text] [Related]
25. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
[TBL] [Abstract][Full Text] [Related]
26. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
[TBL] [Abstract][Full Text] [Related]
27. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
Ohshita H; Tateno C
Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
[TBL] [Abstract][Full Text] [Related]
28. Prediction of circulating human metabolites of pemafibrate, a novel antidyslipidemic drug, using chimeric mice with humanized liver.
Ogawa SI; Uehara S; Tsunenari Y; Kawai H; Suemizu H; Yamazaki H
Xenobiotica; 2020 Jul; 50(7):769-775. PubMed ID: 31766940
[TBL] [Abstract][Full Text] [Related]
29. A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity.
Scheer N; Wilson ID
Drug Discov Today; 2016 Feb; 21(2):250-63. PubMed ID: 26360054
[TBL] [Abstract][Full Text] [Related]
30. Prediction of human disposition toward S-3H-warfarin using chimeric mice with humanized liver.
Inoue T; Sugihara K; Ohshita H; Horie T; Kitamura S; Ohta S
Drug Metab Pharmacokinet; 2009; 24(2):153-60. PubMed ID: 19430171
[TBL] [Abstract][Full Text] [Related]
31. Drug metabolism by cultured human hepatocytes: how far are we from the in vivo reality?
Ponsoda X; Donato MT; Perez-Cataldo G; Gómez-Lechón MJ; Castell JV
Altern Lab Anim; 2004 Jun; 32(2):101-10. PubMed ID: 15601238
[TBL] [Abstract][Full Text] [Related]
32. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
33. Mice with liver composed of human hepatocytes as an animal model for drug testing.
Yoshizato K; Tateno C; Utoh R
Curr Drug Discov Technol; 2012 Mar; 9(1):63-76. PubMed ID: 22023259
[TBL] [Abstract][Full Text] [Related]
34. In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver.
Katoh M; Sawada T; Soeno Y; Nakajima M; Tateno C; Yoshizato K; Yokoi T
J Pharm Sci; 2007 Feb; 96(2):428-37. PubMed ID: 17051594
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.
Foster JR; Jacobsen M; Kenna G; Schulz-Utermoehl T; Morikawa Y; Salmu J; Wilson ID
Toxicol Pathol; 2012 Dec; 40(8):1106-16. PubMed ID: 22673116
[TBL] [Abstract][Full Text] [Related]
36. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
[TBL] [Abstract][Full Text] [Related]
37. The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.
Ekdahl A; Weidolf L; Baginski M; Morikawa Y; Thompson RA; Wilson ID
Arch Toxicol; 2018 Sep; 92(9):2819-2828. PubMed ID: 30094548
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
Li AP
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
[TBL] [Abstract][Full Text] [Related]
39. Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver.
Kikuchi R; McCown M; Olson P; Tateno C; Morikawa Y; Katoh Y; Bourdet DL; Monshouwer M; Fretland AJ
Drug Metab Dispos; 2010 Nov; 38(11):1954-61. PubMed ID: 20693416
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism.
De Serres M; Bowers G; Boyle G; Beaumont C; Castellino S; Sigafoos J; Dave M; Roberts A; Shah V; Olson K; Patel D; Wagner D; Yeager R; Serabjit-Singh C
Xenobiotica; 2011 Jun; 41(6):464-75. PubMed ID: 21370990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
